June 23, 2020 6:49pm

Investors only have a profit once its realized, as percentage (%) movement continues to blow the bubble

Pre-open indications 7 HITs < sold into strength, Adverum Biotechnologies (ADVM +$0.01), Athersys (ATHX -$0.11), Editas Medicine (EDIT +$1.15), Intellia Therapeutics (NTLA -$0.49), Precigen (PGEN -$0.54), CRISPR Therapeutics (CRSP +$3.35)  and a buy - Applied Genetic Technologies (AGTC +$0.39)>  and 1 MISS < bluebird bio (BLUE -$0.58)>

An “intelligence newspaper” for smart investing in the RegMed, gene and cell therapy sector.  Who is feeding your portfolio – profit from RMi’s analysis! Check the BOTTOM LINE …

Subscription is coming, it’s not a conscription but, an offer to join our collective of like-minded investors who make money and for those who read and don’t weep!


Members only. Please login.